STATE STREET CORP - BIOXCEL THERAPEUTICS INC ownership

BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 96 filers reported holding BIOXCEL THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.24 and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of BIOXCEL THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,036,941
-92.5%
409,858
-80.2%
0.00%
-100.0%
Q2 2023$13,800,845
-58.0%
2,072,199
+17.7%
0.00%
-50.0%
Q1 2023$32,854,345
+107.5%
1,760,683
+138.9%
0.00%
Q4 2022$15,833,724
+262.3%
737,138
+99.4%
0.00%
Q3 2022$4,370,000
-9.4%
369,672
+1.2%
0.00%
Q2 2022$4,821,000
-83.5%
365,256
-73.9%
0.00%
-100.0%
Q1 2022$29,290,000
+7.1%
1,400,753
+4.1%
0.00%0.0%
Q4 2021$27,346,000
-32.2%
1,345,096
+1.2%
0.00%
-50.0%
Q3 2021$40,323,000
-4.9%
1,328,599
-8.9%
0.00%0.0%
Q2 2021$42,402,000
-23.0%
1,459,115
+14.4%
0.00%
-33.3%
Q1 2021$55,068,000
-28.8%
1,275,906
-23.8%
0.00%
-40.0%
Q4 2020$77,339,000
+37.9%
1,673,996
+29.4%
0.01%
+25.0%
Q3 2020$56,102,000
+8.6%
1,293,856
+32.8%
0.00%0.0%
Q2 2020$51,652,000
+1731.6%
974,381
+672.2%
0.00%
Q1 2020$2,820,000
+93.2%
126,190
+26.3%
0.00%
Q4 2019$1,460,000
+144.6%
99,950
+17.8%
0.00%
Q3 2019$597,000
+13.5%
84,813
+32.2%
0.00%
Q2 2019$526,00064,1420.00%
Other shareholders
BIOXCEL THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 60,000$151,8000.16%
XTX Topco Ltd 33,605$85,0210.02%
Beacon Pointe Advisors, LLC 301,735$763,3900.01%
AllSquare Wealth Management LLC 4,527$11,4530.01%
Virtus ETF Advisers LLC 4,646$11,7540.01%
Y-Intercept (Hong Kong) Ltd 27,553$69,7090.01%
SeaCrest Wealth Management, LLC 16,550$41,8720.01%
Hennion & Walsh Asset Management, Inc. 33,940$85,8680.01%
Cutler Group LLC / CA 4,000$500.01%
Capital Investment Advisory Services, LLC 17,991$45,5170.00%
View complete list of BIOXCEL THERAPEUTICS INC shareholders